Emergence of Vancomycin-Resistant Enterococci in San Francisco Bay Area Hospitals during 1994 to 1998

Infection Control and Hospital Epidemiology

Volumn 25, Issue 5, 2004, Pages 408-412

  Rosenberg, Jon ^a   Jarvis, William R ^b   Abbott, Sharon L ^a   Vugia, Duc J ^a  

^a Division of Communicable Disease Control   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; DRUG UTILIZATION; ENTEROCOCCUS; HEALTH CARE UTILIZATION; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; NONHUMAN; PATIENT CARE; QUESTIONNAIRE; UNITED STATES;

ENTEROCOCCUS; HOSPITALS, URBAN; HUMANS; QUESTIONNAIRES; SAN FRANCISCO; VANCOMYCIN RESISTANCE;

EID: 2442502563     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502414     Document Type: Article

References (51)

1. Kaplan AH, Gilligan PH, Facklam RR. Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol 1988;26:1216-1218.
2. Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med 2000;342:710-721.
3. Martone WJ. Spread of vancomycin-resistant enterococci: why did it happen in the United States? Infect Control Hosp Epidemiol 1998;19:539-545.
4. Morrison MA, Edwards JR, Horan TC, Richards C, Tokars JI. Changes in the epidemiology of vancomycin-resistant enterococci (VRE) in U.S. intensive care units (ICUs): 1992-2002. Presented at the 14th Annual Meeting of the Society for Healthcare Epidemiology of America; April 17-20, 2004; Philadelphia, PA.
5. Nosocomial enterococci resistant to vancomycin: United States, 1989-93. MMWR 1993;42:597-599.
6. Tokars JI, Paul SM, Crane GL, Cetron MS, Finelli L, Jarvis WR. Secular trends in bloodstream infection caused by antimicrobial-resistant bacteria in New Jersey hospitals, 1991 to 1995. Am J Infect Control 1997;25:395-400.
7. Shay DK, Maloney SA, Montecalvo M, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995;172:993-1000.
8. Morris JG Jr, Shay DK, Hebden JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med 1995;123:250-259.
9. Moreno F, Grota P, Crisp C, et al. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis 1995;21:1234-1237.
10. Washko R, Dow A, Henning KJ. A citywide survey of vancomycin-resistant Enterococcus: New York City, 1993. Clin Infect Dis 1996;22:136-139.
11. Montecalvo MA, Shay DK, Patel P, et al. Bloodstream infections with vancomycin-resistant enterococci. Arch Intern Med 1996;156:1458-1462.
12. Kim WJ, Weinstein RA, Hayden MK. The changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 6-year period. J Infect Dis 1999;179:163-171.
13. Bischoff WE, Reynolds TM, Hall GO, Wenzel RP, Edmond MB. Molecular epidemiology of vancomycin-resistant Enterococcus faecium in a large urban hospital over a 5-year period. J Clin Microbiol 1999;37:3912-3916.
14. Institute of Medicine. Emerging Infections: Microbial Threats to Health in the United States. Washington, DC: National Academy Press; 1992:113-137.
15. Murray BE. Can antibiotic resistance be controlled? N Engl J Med 1994;330:1229-1230.
16. Lorian V. The need for surveillance for antimicrobial resistance. Infect Control Hosp Epidemiol 1995;16:638-641.
17. Centers for Disease Control and Prevention. Statewide surveillance for antibiotic-resistant bacteria: New Jersey, 1992-1994. MMWR 1995;44:504-506.
18. Dembek ZF, Kellerman SE, Ganley L, et al. Reporting of vancomycin-resistant enterococci in Connecticut: implementation and validation of a state-based surveillance system. Infect Control Hosp Epidemiol 1999;20:671-675.
19. Tenover FC, Tokars J, Swenson JM, Paul S, Spiltany K, Jarvis W. Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci. J Clin Microbiol 1993;31:1695-1699.
20. Tenover FC, Swenson JM, O'Hara CM, Stocker SA. Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci. J Clin Microbiol 1995;33:1524-1527.
21. Rosenberg J, Tenover FC, Wong J, Jarvis J, Vugia D. Are clinical laboratories in California accurately reporting vancomycin-resistant enterococci? J Clin Microbiol 1997;35:2526-2530.
22. Facklam RR, Collins MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 1989;27:731-734.
23. Matushek MG, Bonten MJ, Hayden MK. Rapid preparation of bacterial DNA for pulsed-field gel electrophoresis. J Clin Microbiol 1996;34:2598-2600.
24. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-2239.
25. Ostrowsky BE, Venkataraman L, D'Agata EM, Gold HS, DeGirolami PC, Samore MH. Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period. Arch Intern Med 1999;159:1467-1472.
26. Ray AJ, Hoyen CK, Das SM, Eckstein EC, Donskey CJ. Undetected vancomycin-resistant Enterococcus stool colonization in a Veterans Affairs hospital using a Clostridium difficile-focused surveillance strategy. Infect Control Hosp Epidemiol 2002;23:474-477.
27. Landman D, Volkert F, Manikal V, et al. Vancomycin-resistant enterococci in Brooklyn, New York: a moment in time. Clin Infect Dis 1999;29:1587-1588.
28. Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1995;16:105-113.
29. Montecalvo MA, Jarvis WR, Uman J, et al. Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Ann Intern Med 1999;131:269-272.
30. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 2001;344:1427-1433.
31. Byers KE, Anglim AM, Anneski CJ, et al. A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control. Infect Control Hosp Epidemiol 2001;22:140-147.
32. Mayhall CG. Control of vancomycin-resistant enterococci: it is important it is possible, and it is cost-effective. Infect Control Hosp Epidemiol 2002;23:420423.
33. Srinivasan A, Song X, Ross T, Merz W, Brower R, Perl TM. A prospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant enterococci in an intensive care unit. Infect Control Hosp Epidemiol 2002;23:424-428.
34. Goetz AM, Rihs JD, Wagener MM, Muder RR. Infection and colonization with vancomycin-resistant Enterococcus faecium in an acute care Veterans Affairs Medical Center: a 2-year survey. Am J Infect Control 1998;26:558-562.
35. Slaughter S, Hayden MK, Nathan C, et al. A comparison of the effect of universal use of gloves and gown with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 1996;125:448-456.
36. Wells CL, Juni BA, Cameron SB, et al. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis 1995;21:45-50.
37. Boyce JM. Vancomycin-resistant enterococcus: detection, epidemiology, and control measures. Infect Dis Clin North Am 1997;11:367-385.
38. Boyce JM. Consequences of inaction: importance of infection control practices. Clin Infect Dis 2001;33(suppl 3):S133-S137.
39. Jochimsen EM, Fish L, Manning K, et al. Control of vancomycin-resistant enterococci at a community hospital: efficacy of patient and staff cohorting. Infect Control Hosp Epidemiol 1999;20:106-109.
40. Farr BM, Jarvis WR. Would active surveillance cultures help control healthcare-related methicillin-resistant Staphylococcus aureus infections? Infect Control Hosp Epidemiol 2002;23:65-68.
41. Arnold MS, Dempsey JM, Fishman M, McAuley PJ, Tibert C, Vallande NC. The best hospital practices for controlling methicillin-resistant Staphylococcus aureus: on the cutting edge. Infect Control Hosp Epidemiol 2002;23:69-76.
42. Muto CA, Giannetta ET, Durbin LJ, Simonton BM, Farr BM. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2002;23:429435.
43. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362-386.
44. Boyce JM, Pittet D, Healthcare Infection Control Practices Advisory Committee, HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Guideline for hand hygiene in health-care settings. MMWR 2002;51(RR-16):1-44.
45. Wenzel RP, Wong MT. Managing antibiotic use: impact of infection control. Clin Infect Dis 1999;28:1126-1127.
46. Fridkin SK, Edwards JR, Pichette SC, et al. Determinants of vancomycin use in adult intensive care units in 41 United States hospitals. Clin Infect Dis 1999;28:1119-1125.
47. Quale J, Landman D, Saurina G, Atwood E, DiTore V, Patel K. Manipulation of a hospital formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996;23:1020-1025.
48. Schentag JJ, Hyatt JM, Carr JR, et al. Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control Clin Infect Dis 1998;26:1204-1214.
49. Jarvis WR. Epidemiology, appropriateness, and cost of vancomycin use. Clin Infect Dis 1998;26:1200-1203.
50. Cahill CK, Rosenberg J. Guideline for prevention and control of antibiotic resistant microorganisms in California long-term care facilities. Journal of Gerontological Nursing 1996;22:40-47.
51. Trick WE, Kuehnert MJ, Quirk SB, et al. Regional dissemination of vancomycin-resistant enterococci resulting from interfacility transfer of colonized patients. J Infect Dis 1999;180:391-396.